Skip to main content
Peter Scardino, MD, Urology, New York, NY

PeterTScardinoMDFACS

Urology New York, NY

David H. Koch Chair, Attending Urologist, Dept. of Surgery

Dr. Scardino is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Scardino's full profile

Already have an account?

  • Office

    Memorial Sloan Kettering Cancer Center
    Kimmel Center for Prostate and Urologic Cancer, 353 E. 68th St
    New York, NY 10065
    Phone+1 646-422-4329
    Fax+1 646-422-1095

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Urology, 1979
  • Clinical Center at the National Institutes of Health
    Clinical Center at the National Institutes of HealthFellowship, Complex General Surgical Oncology, 1976
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Surgery, 1971 - 1973
  • Duke University School of Medicine
    Duke University School of MedicineClass of 1971

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1975 - Present
  • NY State Medical License
    NY State Medical License 1998 - 2025
  • NJ State Medical License
    NJ State Medical License 2021 - 2023
  • TX State Medical License
    TX State Medical License 1979 - 2000
  • MD State Medical License
    MD State Medical License 1973 - 1983
  • American Board of Urology Urology

Awards, Honors, & Recognition

  • Ramon Guteras Award American Urological Association, 2014
  • Fellow (FACS) American College of Surgeons
  • Barringer Medal American Association of Genitourinary Surgeons, 2009
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Utility of Tacrolimus (FK506) for the Prevention of Erectile Dysfunction Following Bilateral Nerve-S...  
    John P Mulhall, Eric A Klein, Kevin Slawin, Peter T Scardino, The Journal of Sexual Medicine

Authored Content

  • Tumor Copy Number Alteration Burden Is a Pan-Cancer Prognostic Factor Associated with Recurrence and DeathSeptember 2018
  • Identification of Men with Low-Risk Biopsy-Confirmed Prostate Cancer as Candidates for Active Surveillance☆April 2018
  • Identification of Men with Low-Risk Biopsy-Confirmed Prostate Cancer as Candidates for Active Surveillance☆April 2018

Press Mentions

  • Focal Therapy for Prostate Cancer: Should It Become a Standard of Care?
    Focal Therapy for Prostate Cancer: Should It Become a Standard of Care?June 24th, 2022
  • EDAP Hosting Key Opinion Leader Call on Focal One® and ExactVu™
    EDAP Hosting Key Opinion Leader Call on Focal One® and ExactVu™September 15th, 2020
  • 20-Year Follow-up Data Are in: Prostate Cancer Prevention Works; Concerns About High-Grade Disease Dismissed
    20-Year Follow-up Data Are in: Prostate Cancer Prevention Works; Concerns About High-Grade Disease DismissedFebruary 1st, 2019
  • Join now to see all

Grant Support

  • Urologic Oncology Research Training GrantNational Cancer Institute2005–2011
  • Developmental Research ProgramNational Cancer Institute2006–2010
  • Career Development ProgramNational Cancer Institute2006–2010
  • Spore In Prostate CancerNational Cancer Institute2001–2008
  • Urology Oncology Research Training GrantNational Cancer Institute1999–2003
  • Antenoviral Vector Delivery Of HSK TK Gene With Gancivlovir In Prostate CancerNational Center For Research Resources1998–2001
  • Markers Of Progression And MetastasesNational Cancer Institute1996–2001
  • Prostate Neoplasm--Developmental ProjectsNational Cancer Institute1992–2001
  • Prostate Neoplasm--Career Development ProgramNational Cancer Institute1992–2001
  • Spore In Prostate CancerNational Cancer Institute1996–1997
  • Specialized PGM Of Research Excellence/Prostate CancerNational Cancer Institute1992–1995
  • DNA Ploidy And Molecular Markers Of Prostate CancerNational Cancer Institute1992–1995
  • Transrectal Ultrasonography For Prostate CancerNational Cancer Institute1988–1992
  • Chemotherapy Trials For Carcinoma Of The ProstateNational Cancer Institute1985

Professional Memberships